Subcutaneous Injection for Peptides
Subcutaneous injection delivers peptides into the fat layer beneath the skin, where slow absorption from the subcutaneous depot provides sustained plasma levels. This is the default administration route for the majority of self-administered peptides, from BPC-157 to semaglutide.
How It Works
SC injection uses a 27–31 gauge needle, 0.5 inches (12.7 mm) in length, inserted at a 45–90 degree angle into a pinched fold of skin and subcutaneous fat. Insulin syringes (29–31G, 0.5 mL) are the standard for peptide SC injection due to their fine gauge, short needle, and accurate low-volume graduation.
Common injection sites are the abdomen (2+ inches from the navel), outer thigh, and upper arm (posterior-lateral). The abdomen provides the most consistent absorption for most peptides. Rotate injection sites systematically to prevent lipodystrophy — the formation of fat tissue irregularities from repeated injection at the same location.
Technique: clean the injection site with an alcohol swab and let it dry. Pinch a fold of skin and fat between thumb and forefinger. Insert the needle at 45° (lean individuals) or 90° (adequate subcutaneous fat). Inject slowly over 5–10 seconds. Hold for 5–10 seconds before withdrawing. Do not massage the site — this accelerates absorption and may alter the pharmacokinetic profile.
For GLP-1 agonists (semaglutide, tirzepatide), manufacturer-supplied auto-injector pens simplify the process with pre-set doses and hidden needles.
Benefits
Recommended Products (8)
BPC-157
Research-Grade
A 15-amino-acid peptide fragment derived from gastric juice protein BPC, studied extensively in animal models for tissue healing and gut integrity.
CJC-1295 + Ipamorelin
Research-Grade
The most widely used GHRH + GHRP stack — CJC-1295 extends GHRH half-life while Ipamorelin selectively amplifies GH pulses without disturbing cortisol or prolactin.
Ipamorelin
Research-Grade
The most selective GHRP (growth-hormone-releasing peptide) — amplifies GH pulses via ghrelin/GHSR receptor without meaningful cortisol, prolactin, or aldosterone crosstalk.
Semaglutide
Ozempic / Wegovy / Rybelsus
Long-acting GLP-1 receptor agonist — FDA-approved for type-2 diabetes and chronic weight management, landmark for its ~15% mean weight reduction in STEP trials.
Sermorelin
Research-Grade
The first synthetic GHRH analog approved for clinical use — GHRH (1-29) NH₂, the minimum active sequence. Shorter-acting than tesamorelin or CJC-1295.
TB-500 (Thymosin β4 Fragment)
Research-Grade
Synthetic fragment of Thymosin β4 investigated for actin-binding, cell migration, and tissue repair across muscle, cornea, and cardiac models.
Tesamorelin
Egrifta
FDA-approved synthetic GHRH analog indicated for HIV-associated lipodystrophy, studied for visceral adipose tissue reduction and cognitive endpoints.
Tirzepatide
Mounjaro / Zepbound
First-in-class dual GIP/GLP-1 receptor agonist — SURMOUNT trials showed ~20% mean weight reduction and superior A1c control versus semaglutide.
Frequently Asked Questions
Does the injection site matter for SC peptide injections?
What gauge needle is best for peptide SC injections?
How do I prevent bruising at injection sites?
Is IM better than SubQ for peptides?
Other peptide Treatments
Intramuscular (IM) Injection
IM injection delivers peptides into skeletal muscle tissue, where rich blood supply enables faster a…
Intranasal Administration
Intranasal delivery sprays peptide solutions directly into the nasal cavity, where absorption throug…
Oral Peptide Administration
Oral peptide delivery is the most convenient administration route but faces a fundamental biological…
Peptide Reconstitution
Reconstitution is the process of dissolving a lyophilized (freeze-dried) peptide powder in sterile b…
Topical Peptide Application
Topical application is the primary delivery method for cosmetic peptides — signal peptides, carrier …